Literature DB >> 19387741

Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Douglas B Evans1, Michael B Farnell, Keith D Lillemoe, Charles Vollmer, Steven M Strasberg, Richard D Schulick.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19387741     DOI： 10.1245/s10434-009-0416-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  60 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era.

Authors:  Marc W Fromer; Jenci Hawthorne; Prejesh Philips; Michael E Egger; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

3.  Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric vein.

Authors:  Charles H C Pilgrim; Susan Tsai; Parag Tolat; Parag Patel; William Rilling; Douglas B Evans; Kathleen K Christians
Journal:  J Gastrointest Surg       Date:  2013-12-18       Impact factor: 3.452

4.  Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer.

Authors:  Irene Epelboym; J DiNorcia; M Winner; M K Lee; J A Lee; B A Schrope; J A Chabot; J D Allendorf
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

5.  Management of pancreatic cancer: current status and future directions.

Authors:  H Ramesh
Journal:  Indian J Surg       Date:  2010-11-16       Impact factor: 0.656

Review 6.  Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.

Authors:  Matthew H G Katz; Robert Marsh; Joseph M Herman; Qian Shi; Eric Collison; Alan P Venook; Hedy L Kindler; Steven R Alberts; Philip Philip; Andrew M Lowy; Peter W T Pisters; Mitchell C Posner; Jordan D Berlin; Syed A Ahmad
Journal:  Ann Surg Oncol       Date:  2013-02-23       Impact factor: 5.344

Review 7.  Borderline resectable pancreatic cancer.

Authors:  Bhargava Mullapudi; Patrick J Hawkes; Asish Patel; Chandrakanth Are; Subhasis Misra
Journal:  Indian J Surg Oncol       Date:  2015-01-04

Review 8.  Surgical treatment for advanced pancreatic cancer.

Authors:  Hyung Jun Kwon; Sang Geol Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-08-31

9.  Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.

Authors:  Biku J John; Prashant Naik; Alastair Ironside; Brian R Davidson; Guiseppe Fusai; Roopinder Gillmore; Jennifer Watkins; Sakhawat H Rahman
Journal:  HPB (Oxford)       Date:  2013-01-14       Impact factor: 3.647

10.  Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?

Authors:  Sam G Pappas; Kathleen K Christians; Parag P Tolat; Alan P Mautz; Alysandra Lal; Lisa McElroy; T Clark Gamblin; Kiran K Turaga; Susan Tsai; Beth Erickson; Paul Ritch; Douglas B Evans
Journal:  HPB (Oxford)       Date:  2013-03-15       Impact factor: 3.647
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.